Primary Causes & Pathophysiology
DVT develops when normal haemostasis is tipped toward thrombosis, traditionally conceptualised by Virchow's triad: venous stasis (e.g., immobility), endothelial injury (e.g., surgery, trauma), and hypercoagulability (e.g., malignancy, thrombophilia). Thrombi typically originate in the venous valve pockets of the calf, where blood flow is naturally sluggish and hypoxia induces endothelial expression of adhesion molecules and tissue factor. This triggers the coagulation cascade, leading to a fibrin-rich 'red' thrombus that traps red blood cells and platelets. The thrombus can subsequently propagate proximally, increasing the risk of mechanical detachment and embolisation to the pulmonary circulation.
Direct endothelial injury activates the coagulation cascade, while post-operative immobility causes profound venous stasis, fulfilling two components of Virchow's triad.
Tumour cells produce procoagulant substances such as tissue factor and cancer procoagulant, inducing a systemic hypercoagulable state.
Loss of the calf muscle pump mechanism leads to severe venous stasis, allowing local accumulation of activated clotting factors in venous valve pockets.
Hormonally induced physiological hypercoagulability (increased factors VII, VIII, X, and fibrinogen) combined with mechanical venous compression of the iliac veins by the gravid uterus.
Genetic defects in the coagulation cascade or natural anticoagulant proteins lead to an uninhibited procoagulant state.